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ABSTRACT 
Stent geometries are obtained by topology optimisation for minimised compliance under different stenosis 
levels and plaque material types.  Three levels of stenosis by cross-sectional area, i.e. 30%, 40% and 50% 
and three different plaque material properties i.e. calcified, cellular and hypocellular, were studied. The 
raw optimisation results were converted to clear design concepts and their performance was evaluated by 
implanting them in their respective stenosed artery types using finite element analysis. The results were 
compared with a generic stent in similar arteries, which showed that the new designs showed less recoil. 
This work provides a concept that stents could be tailored to specific lesions in order to minimise recoil and 
maintain a patent lumen in stenotic arteries.
1 INTRODUCTION 
Cardiovascular disease (CVD) is the main cause of death in England and Wales, with 
approximately 124,000 deaths per year, among which nearly half are due to 
atherosclerosis [1]. In atherosclerosis plaque is accumulated in the coronary arteries, 
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restricting the flow of oxygen-rich blood to the heart muscle. Treatment of these 
narrowed arteries mainly involves the placement of balloon-expandable stents, which are 
usually metallic wire mesh inserts that support and expand the diseased vessel, allowing 
blood flow to be restored.  
Since their first use in 1986 [2], stents have evolved in terms of design, materials and drug 
coatings to achieve better post-implantation results. Presently, the main concern about 
this treatment is restenosis, or the re-blocking of the stented artery, normally known as 
in-stent restenosis (ISR). There are a variety of stent designs available, each differing with 
regard to material, strut thickness, coating and drug elution. It is known that stent 
varieties trigger different vascular responses and a number of desired attributes have 
been identified in the literature, including biocompatible surface material, thinner struts, 
modular design, low recoil and low material surface area [3–7]. Stenting is not risk free 
and poor stent design can contribute to re-blocking conditions, such as thrombosis and 
neointimal hyperplasia [8]. These adverse conditions mainly depend upon how the stent 
geometry interacts with the arterial surface and the resulting effects on blood flow. 
Currently, stenting (stent deployment) of diseased arteries involves the use of “off-the-
shelf” devices. This lack of personalisation raises the potential risk of suboptimal stent 
deployment in the target’s diseased vessel. This is particularly the case when treating 
diseased arteries with severely calcified plaques, which can result in low lumen area and 
shape. 
It is known that with the progression of atherosclerosis, plaque composition and 
mechanical properties vary considerably and plaque histological types such as cellular, 
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hypocellular and calcified have been found to have statistically different radial 
compressive stiffness [9]. To take lesion properties, such as shape and stiffness, into 
account during stent design is, hence, of great importance. It was shown in a recent study 
of self-expanding stents [10] that lesion calcification of the arterial wall could lead to a 
more severe residual stenosis, dog-boning effect and corresponding edge stress 
concentrations after stenting. This ultimately could mean that the stent may not be able 
to serve its purpose-to adequately support the diseased artery. Zhao et al. [10] 
investigated soft and hard plaques, both causing a stenosis of 50%. After stent 
deployment, whilst the artery with the soft plaque experienced a residual stenosis of 15%, 
39% residual stenosis still existed in the case with the stiffer plaque, which does not satisfy 
the allowable residual stenosis standard of 30% or less [11,12]. It is therefore vital to 
consider design changes to the stent to achieve acceptable lumen diameter in such 
calcified arteries.  
In another study, Garcia et al. [13] investigated the design of a variable radial stiffness, 
self-expanding stent for a carotid artery with a calcified plaque. It was emphasised in their 
study that all desirable features in a stent are hard to achieve at the same time, therefore 
it is necessary to reach a compromise between tissue stress, stent flexibility and radial 
force. In their investigation they mainly focused on altering the strut thickness of the stent 
to achieve minimal contact pressure in the healthy region of the artery during expansion. 
Pericevic et al. [14] investigated the influence of plaque materials on a selected stent 
based on balloon-expandable design and concluded that plaque type has a significant 
effect on the stresses induced within an artery which may alter arterial response. These 
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studies provide the evidence of the impact of lesion types on the outcome of stenting 
procedure and demonstrate the need to develop customised stent geometries for specific 
lesion types.  
In order to create customised stents, it is crucial to accurately measure and map the forces 
acting on stents exerted by complex lesions. Current procedure for arterial assessment 
involve intravascular ultrasound (IVUS) that mainly relies on acoustic reflections to 
determine plaque composition [15], other methods include computed tomography (CT) 
scanning [16], cardiac magnetic resonance (CMR) [17,18] and optical coherence 
tomography (OCT) [19]. However, advancements in arterial imaging and sensing 
technologies, and the conversion from images to in silico models will be necessary in 
order to benefit from customisation. Researchers have recently developed stretchable 
polymer-electronic balloon catheters from novel materials containing dense arrays of 
sensors and therapeutic modules [20,21]. These catheters could be used to provide 
information with high sensitivity about the local arterial microenvironment such as 
temperature, material type and force exerted by lesions. In this paper, we have used a 
similar concept by exploiting finite element analysis (FEA) and implanting a cylinder in 
silico into a set of stenotic arteries to extract the exact forces applied by the arteries to 
tailor stent designs using topology optimisation. 
Recent studies [22,23] have suggested bioresorbable stents, commonly referred to as 
scaffolds, as a possible future option for coronary intervention. As a consequence, 
polylactic acid (PLA) was chosen as the material during the design process. Bioresorbable 
stents have the advantage of natural absorption by the body after functioning for the 
Journal of Medical Devices 
 
MED-15-1278  Wildman 7 
ASME © 
required period of time. No longer being present in the body as a permanent implant, the 
risk of restenosis is reduced as well as allowing the artery to resume its beneficial natural 
vasomotion.  
Topology optimisation (TO) is a type of structural optimisation method where the aim is 
to find the optimal material distribution and connectivity of structural elements [24]. 
Various approaches have been proposed for TO [25–33], which is gaining attention in a 
wide variety of applications. TO based contact analysis of stent and diseased artery is a 
novel approach to take into account the accurate loading conditions of different plaque 
types to customise stent architectures according to specific lesions while maintaining 
vessel lumen area. Although many groups have researched the biomechanical 
performance of stents using finite element methods [13,34–38], including very limited 
stent TO studies [39–41], topological optimisation has not been explored in the plaque-
specific stent design fields. This paper aims to demonstrate that TO can be used to 
generate designs that enable recoil to be minimised even in conditions where there are 
strong variations in material property and surface topology of the lumen side of an artery, 
particularly in the axial direction. 
2 METHODS 
In this paper, a set of topologically optimised PLA stents were developed and their 
performance investigated and compared to a generic stent in terms of their radial 
deformation after implantation in a set of virtual stenosed arteries. The optimised stents 
are obtained through the solid isotropic material with penalisation (SIMP) [42] method of 
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topology optimisation. The proposed design method has three essential steps, as shown 
in Figure 1 and described below, and was carried out for each combination of plaque type 
and stent. 
(i) A contact finite element analysis involving a stenotic artery of particular type and 
a cylindrical tube, representing the design domain for a stent topology. The 
extracted force from this analysis acts as a loading boundary condition for step (ii). 
(ii) Topology optimisation of a stent, based on extracted contact normal forces from 
step (i). 
(iii) Contact analysis of generic and optimised stents with the corresponding 
diseased artery for performance evaluation in terms of radial deformation. 
A complete topology optimisation driven design process is illustrated in Figure 2, outlining 
the development and production of lesion-specific stents. 
2.1 Geometric Models and Material Properties 
 
The finite element models used in this study were developed using MSC.Patran and 
MSC.Marc was employed as the non-linear solver (MSC Software, Santa Ana, CA). Each 
stenosed artery was defined by two different parameters: stenosis level and plaque 
material type. With 3 stenosis levels: 30%, 40%, 50% by area and 3 plaque material types: 
calcified, cellular and hypocellular, hence, 9 different diseased artery models were 
created. The plaques modelled were eccentric and covered a length of 10 mm with 
maximum wall thickness of 0.66 mm, 1.0 mm and 1.24 mm corresponding to a stenosis 
of 30%, 40% and 50% respectively. Percent stenosis cross-sectional areas were calculated 
as: 100 x [1 – (Stenotic lumen area/Original lumen area)]. The artery was modelled as a 
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straight vessel with a length of 20 mm and inner radius of 2.22 mm. The thickness of 
atherosclerotic human coronary arteries range from 0.5 to 1.2 mm, depending on location 
[43]; in our study a thickness of 0.5 mm was chosen. Figure 3 illustrates XZ cut view of the 
stenotic arteries used. 
Each simulation model was composed of two bodies, a diseased artery and a cylinder 
acting as a force sensing balloon catheter (or the generic stent for comparison with 
optimised designs). The generic stent (Figure 4) selected was inspired by the 
bioabsorbable Igaki-Tamai stent [44], and was chosen on the basis that it captured the 
main features of most commercially available designs, without being specific to a 
particular type. The cylinder used in each scenario, had outer radius of 2.57 mm (greater 
than the artery), length of 15mm and thickness of 0.2 mm. The generic stent had an outer 
radius of 2.45 mm and was assumed to be in a nearly expanded state. The material used 
for the generic stent and the force extracting cylinder was modelled as an elasto-plastic 
polylactic acid (PLA) polymer blend, having elastic modulus, E = 3.5 GPa, yield stress σy = 
60 MPa and Poisson’s ratio, ν = 0.36, based on data in the literature [45–47]. The artery 
and 3 plaque types were modelled with a third-order non-linear hyperelastic material 
model, as suitable for an incompressible isotropic material.  This has previously been 
found to adequately describe the non-linear stress-strain relationship of elastic arterial 
tissue, and is given by [48] 
W= C10(I1-3) + C01(I2-3) + C20(I1-3)
2 + C11(I1-3)(I2-3) + C30(I1-3)
3         (1) 
where W is the strain-energy density function of the hyperelastic material, I1, I2 and I3 are 
the strain invariants and C10, C01, C20, C11, C30  are the hyperelastic constants. Table 1 
Journal of Medical Devices 
 
MED-15-1278  Wildman 10 
ASME © 
summarises the constants used for the hyperelastic constitutive equations to define the 
4 material types.  
2.2 Meshing and Boundary Conditions 
Eight noded first order hexahedral, full integration elements were used to mesh all the 
atherosclerotic artery models. Mesh convergence studies, as shown in Figure 5, were 
carried out for one of the artery models to select an appropriate mesh size. The results 
demonstrate that 41760 elements in the artery and plaque are a reasonable compromise 
between accuracy and computational efficiency. The cylinder used for contact normal 
force sensing was modelled as a shell mesh of 6804 quad 4 elements. This was also used 
as the design domain for stent optimisation. The generic stent consisted of 6849 quad 4 
shell elements. 
The boundary conditions applied were comprised of an internal pressure, displacement 
boundary conditions and contact. The artery and cylinder/stent were constrained axially 
and allowed to expand and contract radially. The cylinder/stent in each case was first 
positioned inside the artery with elements, as shown in Figure 6, deactivated. The vessel 
was then inflated by applying pressures of 32.5 MPa for 30% and 40% stenosis and 65.05 
MPa for 50% stenosis. These pressure values expanded the corresponding arteries 
enough such that the slightly oversized cylinder could be positioned inside or 
“implanted.” This process was carried out in two load case steps; first, the cylinder 
elements were deactivated from the contact table such that the artery could expand 
freely. In the second step, cylinder elements were activated in the contact table, pressure 
was then reduced to diastole (0.013 MPa) such that the artery wrapped around the 
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cylinder. For the analysis involving generic stent, internal pressure was applied to stent 
initially to expand and plastically deform while stenotic artery elements were deactivated. 
The pressure was then removed to allow the stent to recoil and achieve its final diameter 
of 5.15 mm. The stenotic artery in each case was then inflated and deflated in the last 
load case to wrap around the stent as performed in previous analyses. Contact between 
artery models and the cylinder was defined as deformable-deformable ‘touch’ contact. 
All the artery models were solved for contact analysis separately in the same manner. 
After performing the contact analysis of the cylinder with each type of diseased artery, 
the contact normal forces on the cylinder imposed by the vessel in each case were applied 
as loads on the same cylindrical stent design domain, for optimisation. 
2.3 Topology Optimisation 
The next step was to perform the topology optimisation. Topology optimisation can 
provide an optimised “design concept” of materials distribution, potentially achieving 
greater design improvement than size and shape optimisation [49]. In this case the aim 
was to achieve a stent design concept to best suit lesion-specific conditions. The objective 
was to minimise the compliance  𝐶∗ of the structure (where  𝐶∗ is the reciprocal of 
stiffness) while satisfying the constraints of volume fraction (while being in the range of 
current stents in practice in terms of stent-artery area coverage ratio) under contact 
loading conditions of the stenotic artery. The compliance of a structure is defined as 
 𝐶∗ = 𝑼𝑇𝑭        (2) 
where 𝑼 is the global displacement vector and 𝑭 is the global force vector applied to the 
structure. The strain energy S of the structure is defined as 
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S = 
1
2
 𝑼𝑇𝑭     (3) 
Assuming constant 𝑭, minimising compliance would mean minimising strain energy or the 
deformation 𝑼, in an elastic regime. The density method or the solid isotropic material 
with penalisation (SIMP) method was applied for stent topology optimisation [50–52] 
using MSC Nastran. The SIMP method assigns an internal element density 𝑥𝑖  to each 
element, which is the design variable of the optimisation.  
The SIMP method then minimises compliance as follows 
 
Objective:     min 𝐶∗ = 𝑼𝑇𝑭          (4) 
 𝐶∗ = 𝑼𝑇𝑲𝑼 = ∑ 𝑢𝑖𝑘𝑖𝑢𝑖
𝑁
𝑖=1
 
                                                             = ∑ (𝑥𝑖)𝑝𝑢𝑖𝑘0𝑢
𝑖𝑁
𝑖=1
      
Subject to volume constraint:    𝑉 = ∑ 𝑥𝑖𝑣𝑖 ≤ 𝑉0 −  𝑉
∗𝑁
𝑖=1
        (5) 
     𝑭 = 𝑲𝑼 
                                                  𝑘𝑖 = (𝑥𝑖)𝑝 𝑘0      
      0 < 𝑥𝑚𝑖𝑛 ≤ 𝑥
𝑖 ≤ 𝑥𝑚𝑎𝑥 < 1 
where 𝑲 is the stiffness matrix of the stent structure, 𝑢𝑖 is the displacement vector of the 
nodes, N is the total number of elements, 𝑘0 and 𝑘
𝑖 are the element’s initial  stiffness and 
the stiffness matrix after optimisation, respectively.  
In the constraints, 𝑉 is the volume of the structure after optimisation which in our case 
was set to 0.3 (30%) based on being in the range (25%-65%) of currently available polymer 
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stents [53]. 𝑉0 is the initial volume, 𝑉
∗ the amount of material to be removed, 𝑣𝑖  is the 
element volume after optimisation. 
The density design variable 𝑥𝑖 of each element has a value ranging between 0 (void) and 
1 (solid). Elements with values close to 0 can be discarded, since they represent regions 
where little stress is being carried, whilst those nearest to 1 are bearing the largest load. 
𝑥𝑚𝑖𝑛 is the lower bound of element density and 𝑥𝑚𝑎𝑥  is the upper bound of element 
density. The reason for keeping a lower bound for the density instead of restricting it to 
zero is to avoid singularity of the system’s matrices. A penalty factor p is introduced to 
enforce the design variable to be close to 0-1 solution when p>1.0 [42]. A recommended 
value of 3 is used for this problem, this approach is simple and the optimised design 
consists of clear solid and void without the undue suppression of local optima. 
2.4 Comparison with a Generic Stent 
The main aim of stent implantation is to keep the artery open by pushing the plaque 
against the arterial wall. Therefore a stent should have enough radial stiffness to deal with 
different types of plaques in terms of their shape and stiffness. In this study a set of plaque 
types with different size and stiffness have been used, hence focus is kept on the stent 
performance in terms of radial recoil after implantation. After performing contact analysis 
of the new optimised stents with their respective stenotic artery types, the final step of 
the study was to simulate a typical generic stent in similar fashion and compare its radial 
deformation to the topologically optimised stents. The generic stent used was expanded 
with the help of internal pressure of 0.52 MPa such that it plastically deformed to its final 
diameter of 5.15 mm inside corresponding arteries. 
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3 RESULTS & DISCUSSION 
As described above, the initial contact analyses involving the artery models with the 
cylinder were used to generate a set of contact normal forces acting radially inward on 
the cylinder for each case, to be used as the input load for the topology optimisation. An 
example of the resultant radial force from a contact analysis is shown in Figure 7.  This 
Figure depicts the contour plot of the radially inward nodal forces on the cylinder. It could 
be noted in Fig. 7b that highest load is acting on the top centre due to peak plaque 
thickness (results of axial-stent-half unwrapped from cylindrical shape for illustration 
purpose). 
Topology optimisation using the force distribution from the contact analysis was used to 
generate the optimal material distribution of material for the 9 different plaque loading 
conditions. Figure 8 shows the normalised material density distribution, from TO with a 
0.3 volume fraction constraint. The resulting amount of material in each optimised stent 
was similar to the generic stent (varying less than 5%). The results were unwrapped using 
MATLAB to form a flat 2-D plot for illustration purposes. It can be seen that there is a 
higher material density in the central part of the stent, as a consequence of the plaque 
induced higher forces here as previously shown in Figure 7, especially in the centre of the 
lower half of each stent where it comes into contact with the thickest part of the plaque 
in each case. 
Matlab and image editing software were used to unwrap, construct and smooth the 
optimisation geometry in order to transform it into an analysable stent structure, as 
illustrated in Figure 9. This modification lead to an additional 5-10% volume increase of 
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the stent but the overall volume remained in the range of current stents in practice. The 
smoothed optimised stent results were then wrapped to form cylindrical shapes and 
solved for contact analysis with their respective arteries in the same manner as the 
contact FEA with the force extracting cylinder. The final lumen radial deformation of 20 
equidistant points in each of the diseased arteries along the thickest part of plaque were 
recorded to provide a comparative measure of the ability of the stent to maintain arterial 
opening. 
For comparison, the first step was to evaluate recoil of generic stent in unstenotic and 
stenotic arteries with different plaque materials for 30, 40 and 50% stenosis levels 
respectively as shown in Figure 10a-10c.  Plaque peak thickness in the 30% stenosis 
protruding inside the artery had a minimum unstented radius 1.56 mm, as shown in Figure 
10d. After implantation of optimised stents, this increased to 2.43 mm, 2.54 mm and 2.54 
mm for calcified, cellular and hypocellular plaques respectively with the corresponding 
optimised stent. In the same scenario, lumen position values after generic stent 
implantation were 2.17 mm, 2.29 mm and 2.24 mm for calcified, cellular and hypocellular 
plaques respectively. In the 40% stenotic artery, the unstented minimum position from 
central axis was, as expected, even less than with the 30% plaque, at 1.22mm. After 
stenting with the optimised designs, lumen gain was achieved, with the minimum radius 
increasing to 2.24 mm, 2.51 mm and 2.34 mm for calcified, cellular and hypocellular 
plaques respectively, with the corresponding optimised stent as illustrated in Figure 10e. 
Results in the same environment with generic stent were 1.68 mm, 2.13 mm and 2.0 mm 
for calcified, cellular and hypocellular plaques respectively. Similarly for 50% artery 
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stenosis, plaque peak thickness had an unstented position of 0.972 mm in the Z direction. 
After stenting this increased to 2.06 mm, 2.49 mm and 2.50 mm for calcified, cellular and 
hypocellular respectively, with the corresponding optimised stent (Figure 10f). In similar 
conditions, lumen positions with a generic stent were 1.54 mm, 1.97 mm and 1.78 mm 
for calcified, cellular and hypocellular plaques respectively. 
Analysis of the generic stent studied shows that severe calcification could lead to 
immediate lumen gain after the implantation of self-expanding stents as illustrated in 
Figure 10,11. The generic stent deployed in the calcified 30%, 40% and 50% diseased 
vessel, recoiled significantly more than the optimised stents in the central region leading 
to 10%, 29% and 35% residual stenosis respectively (Figure 10a-10c & 11). This was in 
agreement with a previous study mentioned earlier [4]. In other words, in spite of having 
similar volume of material, the stent showed less efficacy in supporting the disease and 
the displacement could not meet the limits of standard stenting effectiveness of 30% or 
lower allowable immediate post-implantation residual stenosis [11,12].  
These results reveal the potential of the proposed design method, utilising contact FEA 
and topology optimisation, to generate optimised stents able to restore the lumen area 
to an acceptable level for given plaque types, i.e. resulting recoil lower than 30% residual 
stenosis, whilst retaining beneficial features, such as lower stent volume. It could be 
noted that the calcified lesion, owing to its greater stiffness, leads to slightly lower stented 
lumen area compared to the other plaque types in all types of stenosis; optimised stent 
performance post stenting is still acceptable. The proposed method also has the potential 
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to eliminate the need for balloon angioplasty and related procedures, which are 
commonly performed to create a more uniform lesion to be stented [54].  
The results obtained from the topology optimisation give a concept design and 
demonstrate that stents could be tailored according to the accurate loading conditions in 
specific-plaques geometries. Topology optimisation results are normally mesh-
dependent and therefore could be further investigated by employing different methods 
to refine the desired solution. One such recently developed method [33] is the use of 
extended finite element method (X-FEM), in combination with an evolutionary 
optimisation method that allows to obtain smooth and clearly defined structural 
boundaries and would potentially reduce the need to modify the TO results to obtain a 
manufacturable design.  
4 LIMITATIONS AND FUTURE WORK 
 
The current work does not consider stent crimping and expansion process in the design 
approach and is focused on early-stage topology optimisation to achieve geometries at a 
conceptual stage. A complete, but challenging solution is to use a topology optimisation 
method to create a compliant mechanism [55] and simulate implantation. However, one 
is not always dependent on plastic deformation to fix a stent, for example, another one 
potential route is to incorporate a ratchet-like mechanism to the designs similar to the 
REVA stent and a recoil prevention device [53,56,57], which upon balloon expansion has 
struts that slide and lock without plastic deformation of the stent. In the future, a more 
complete study will involve the examination of curved and bifurcating systems, as well as 
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the importance of advanced material models including anisotropic, plastic and failure 
modes [58,59]. Further studies should also consider other materials such as stronger 
bioresorbable polymers and biocompatible super-elastic alloys such as nitinol. 
This approach to design of stents will likely realise complex topographies that will be 
difficult to manufacture with traditional techniques. Whilst these could be manufactured 
using, for example, laser cutting methods common for stent production, a technology for 
the future is additive manufacturing (AM). Production and modification of metallic stents 
via AM has already been demonstrated and printable polymeric biomaterials for drug 
release and implants are becoming more widely available [60–67]. The workflow 
presented here has potential benefit not only for the personalised treatment of CVD; the 
scalability and freedom of design based AM offers a benefit for other intravascular 
applications.  The combination of design, additive manufacturing and identification of 
patient specific arterial geometries and properties offers considerable patient benefit. 
5 CONCLUSION 
 
A topology optimisation method has been applied to the optimisation of stent geometry 
for a set of specific lesion sizes and types. After transforming the TO results to 
manufacturable design concepts, it has been demonstrated that such designs are able to 
maintain lumen area to a greater degree than a selected generic design. Through 
mechanical design the stent recoil was reduced, even under conditions of significant 
stenosis and strong variations in the material solid rheology. 
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NOMENCLATURE 
 
E elastic modulus 
ν Poisson’s ratio 
σy yield stress 
W strain energy density function 
C hyperelastic constants 
I strain invariants 
C* compliance 
𝑼 global displacement vector 
𝑭 global force vector 
S strain energy 
𝑲 stiffness matrix 
N total number of elements 
𝑢𝑖 displacement vector of the nodes 
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𝑘𝑖 stiffness matrix after optimisation 
𝑘0 elements initial stiffness 
𝑥𝑖 initial element density 
𝑉0 initial volume 
𝑉 volume of the structure after optimisation 
𝑉∗ amount of material to be removed 
𝑣𝑖  element volume after optimisation 
𝑥𝑚𝑖𝑛 lower bound of element density 
𝑥𝑚𝑎𝑥 upper bound of element density 
p penalty factor 
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Table Caption List 
 
Table 1 Hyperelastic constants to describe plaque and arterial tissue [48]. 
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Figure Captions List 
 
Fig. 1 Analysis steps. 
Fig. 2 Proposed approach to design lesion-specific stents. 
Fig. 3 Artery models with plaque types used for the analyses (XZ plane cut view). 
Fig. 4 Generic stent used for comparison. 
Fig. 5 Maximum radial displacement of plaque tip in the artery with five 
different meshes. 
Fig. 6 Relative position of cylinder and 40% stenotic artery before contact (artery 
sliced for illustration purpose). 
Fig. 7 Contour plot showing radially inward nodal load (N) variation on one of 
the 9 design spaces for stent topology optimisation based on cylinder-
artery contact with 50% calcified stenosis (a), discrete load contour plot 
unwrapped from cylindrical shape for illustration purpose showing axial 
(X) and circumferential (ϴ) directions (b). 
Fig. 8 Stent topology optimisation density distribution results for (a-c) 30%, (d-f) 
40% and (g-i) 50% stenosis for calcified, cellular and hypocellular plaque 
types respectively (results of axial-stent-half unwrapped from cylindrical 
shape for illustration purpose). 
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Fig. 9 Stent topologies for (a-c) 30%, (d-f) 40% and (g-i) 50% for calcified, cellular 
and hypocellular plaque types respectivelys, (results of axial-stent-half 
unwrapped from cylindrical shape for illustration purpose). 
Fig. 10 Final lumen radial deformation with a generic stent (a-c) and optimised 
stents (d-f) for 30, 40 and 50% stenotic arteries respectively with different 
plaque types based on 11 equally distant points longitudinally along 
thickest part of plaque, relative to central axis (one half of the stenotic 
artery deformations illustrated). 
Fig. 11 Post implantation stenosis levels (calculated by lesion cross-sectional 
area) in the remodeled artery due to optimised and generic stents recoil. 
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Table 1 
Constants 
Arterial Tissue 
(MPa) 
Calcified Plaque 
(MPa) 
Cellular Plaque 
(MPa) 
Hypocellular Plaque 
(MPa) 
C10 0.025466 -0.4959 -0.8027 0.1651 
C01 -0.011577 0.5066 0.83163 0.01696 
C20 -0.000506 3.6378   
C11 0.001703 1.19353 1.1578 0.9553 
C30 0.00165 4.7372   
 
 
 
 
 
